ANG1005

GRN1005 · Angiochem Inc

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ANG1005, covering 2014-07-31 to 2023-04-24. Get the full timeline:

Most recent: Clinical Trial Update: ANG1005 in Leptomeningeal Disease From Breast Cancer [Phase 3]